Tcoag
Tcoag Ireland Limited is a Stago Group subsidiary that manufactures and globally distributes coagulation and hemostasis analyzers (DT 100, KC series, Destiny line) and reagents, including the TriniLIA D-Dimer II assay, serving hospital and clinical laboratories across 70+ countries.
- Company typePrivate
- Founded2010
- HeadquartersIrishtown, Ireland
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Tcoag does
Tcoag Ireland Limited is a privately held medical device manufacturer specializing in coagulation and hemostasis diagnostics. The company is a wholly-owned subsidiary of the Stago Group (Diagnostica Stago) and serves as the group's global commercial headquarters, based in Bray, Co. Wicklow, Ireland. Tcoag's product portfolio spans automated and semi-automated coagulation analyzers — including the DT 100 (fully automated benchtop with dual optical and mechanical detection), the KC1 Delta and KC4 Delta (semi-automated mechanical clot detection analyzers), and the Destiny Max and Destiny Plus (high- and medium-throughput haemostasis analyzers) — together with a comprehensive reagent line including the TriniLIA D-Dimer II immunoturbidimetric assay for VTE rule-out and reagents for thrombophilia testing. The company also operates the Qualiris external quality assessment (EQA) programme, an ISO/IEC 17043-accredited inter-laboratory comparison service, and the Thrombinoscope software for thrombin generation measurement.
The business operates a razor/razorblade revenue model combining instrument sales (capital revenue) with ongoing reagent and consumable sales (recurring revenue), supplemented by service and EQA programme fees. Manufacturing is split by product type: reagent kits are produced in Bray, Ireland, while coagulation instruments are manufactured in Lemgo, Germany, with R&D functions maintained across France, Ireland, and Germany. Tcoag sells directly through wholly-owned sales entities in nine countries (Austria, France, Germany, Italy, Portugal, Spain, Switzerland, UK, USA) and reaches additional markets through distribution partners in over 70 countries worldwide.
The end customer base consists of medical laboratories — primarily hospital and clinical laboratories performing coagulation, hemostasis, and thrombosis diagnostics for patient diagnosis and monitoring. The company emphasizes proprietary patented mechanical clot detection (the Amelung Ball Method, in use since the 1970s) and dual-technology analyzer platforms that mitigate interference from lipemic, icteric, and hemolysed samples, positioning accuracy and reliability on compromised samples as the primary technical differentiator versus optical-only competitors.
Tcoag firmographics
Firmographics- Name
- Tcoag
- Legal name
- Tcoag Ireland Limited
- Website
- https://tcoag.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Tcoag Ireland Limited is a Stago Group subsidiary that manufactures and globally distributes coagulation and hemostasis analyzers (DT 100, KC series, Destiny line) and reagents, including the TriniLIA D-Dimer II assay, serving hospital and clinical laboratories across 70+ countries.
- Ownership category
- akta.pro rank
Tcoag industry classification
Industry- Product category
- In-Vitro Diagnostics (Coagulation/Hemostasis)
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823)
- akta.pro primary industry
- Hematology & Coagulation Diagnostics (HLAHAAAB)
- akta.pro secondary industries
- Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
Keywords
Where Tcoag is headquartered
LocationHeadquarters
- HQ city
- Irishtown
- HQ country
- Ireland
- HQ region
- Europe
Offices14 records
Markets served
Tcoag business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Coagulation Instruments: Sale of automated and semi-automated coagulation analysers including DT 100, Destiny Max, Destiny Plus, KC1 Delta, and KC4 Delta for medical laboratories.
- Reagents and Consumables: Sale of coagulation reagent test kits, calibrators, controls, and consumables for use with the company's instrumentation.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Tcoag product offering
Product offeringCore offering
Tcoag manufactures and sells a complete line of automated and semi-automated coagulation analyzers together with a comprehensive reagent portfolio for hemostasis testing. Its instruments combine dual optical-mechanical detection technologies with proprietary methods such as the Ball Method, while the reagent range covers routine screening, thrombophilia, and D-Dimer testing for clinical and hospital laboratories. The offering is rounded out by the Qualiris external quality assessment program for laboratory performance benchmarking.
Product overview
Tcoag is a coagulation company offering a comprehensive portfolio of haemostasis instrumentation and reagents. The product lineup includes four main analyzer models: DT 100 (fully automated benchtop with dual optical/mechanical technology for mid-to-high volume labs), KC4 Delta and KC1 Delta (semi-automated analyzers with micro-mechanical clot detection), and Destiny Max/Destiny Plus (high/medium throughput haemostasis analyzers with patented Ball Method mechanical testing). The reagent portfolio includes TriniLIA D-Dimer II for VTE diagnosis and comprehensive thrombophilia testing reagents, supported by Qualiris external quality assessment services and Thrombinoscope software for thrombin generation measurement. The company operates as part of the Stago Group, with manufacturing facilities in Ireland (reagent kits) and Germany (instrumentation), and direct selling entities in Austria, France, Germany, Italy, Portugal, Spain, Switzerland, UK, and USA, plus distribution partners in over 70 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Qualiris: International external quality assessment (EQA) programme for inter-laboratory comparison (ILC) business, ISO/IEC 17043 accredited
- Thrombinoscope
- DT 100
- TriniLIA
Products and services
- DT 100 Coagulation Analyzer
Companies that use Tcoag
Customer profileSegments1 record
Ideal customer profiles1 record
Tcoag technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Tcoag partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Tcoag competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Tcoag compliance and trust
Trust signalCompliance1 record
Tcoag financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tcoag leadership team
Management profileNumber of profiles
Tcoag subsidiaries and ownership
Company hierarchySubsidiaries13 records
Tcoag funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tcoag M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tcoag
What does Tcoag do?
Tcoag manufactures and sells a complete line of automated and semi-automated coagulation analyzers together with a comprehensive reagent portfolio for hemostasis testing. Its instruments combine dual optical-mechanical detection technologies with proprietary methods such as the Ball Method, while the reagent range covers routine screening, thrombophilia, and D-Dimer testing for clinical and hospital laboratories. The offering is rounded out by the Qualiris external quality assessment program for laboratory performance benchmarking.
Is Tcoag a public or private company?
Tcoag is a private company. It is classified as corporate owned and is currently operating.
When was Tcoag founded?
Tcoag was founded in 2010. It employs 251 to 500 people.
Where is Tcoag based?
Tcoag is headquartered in Irishtown, Ireland, in the Europe region.
How does Tcoag make money?
Two revenue lines are on record. Coagulation Instruments are the primary driver. The others are reagents and Consumables.
Does Tcoag have an API?
No public API is recorded for Tcoag.
What industry is Tcoag in?
Tcoag's product category is In-Vitro Diagnostics (Coagulation/Hemostasis). Its primary akta.pro industry code is HLAHAAAB, Hematology & Coagulation Diagnostics, with a secondary code of HLAAALAH, Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing). Its NAICS code is 334516 and its SIC code is 2835.